• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Jumps 100 Points; Tyson Foods Sales Miss Views

    5/6/24 11:14:14 AM ET
    $EYPT
    $GLYC
    $LYRA
    $SGE
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $EYPT alert in real time by email

    U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 100 points on Monday.

    The Dow traded up 0.25% to 38,772.28 while the NASDAQ rose 0.64% to 16,260.19. The S&P 500 also rose, gaining, 0.59% to 5,157.96.

    Check This Out: Wall Street’s Most Accurate Analysts’ Views On 3 Tech & Telecom Stocks Delivering High-Dividend Yields

    Leading and Lagging Sectors

    Energy shares rose by 1.5% on Monday.

    In trading on Friday, consumer staples shares fell by 0.4%.

    Top Headline

    Tyson Foods Inc (NYSE:TSN) reported weaker-than-expected sales for its second quarter.

    The company posted a second-quarter FY24 sales decline of 0.46% year-on-year to $13.072 billion, missing the analyst consensus estimate of $13.157 billion. Adjusted EPS of 62 cents beat the consensus estimate of 39 cents.

    Equities Trading UP
                           

    • Holdco Nuvo Group D.G Ltd (NASDAQ:NUVO) shares shot up 222% to $6.57.
    • Shares of Strong Global Entertainment, Inc. (NYSE:SGE) got a boost, surging 150% to $2.84 fter FG Acquisition Corp. announced the proposed acquisition of Strong/MDI Screen Systems and the launch of Saltire Holdings.
    • XBP Europe Holdings, Inc. (NASDAQ:XBP) shares were also up, gaining 62% to $3.4293. XBP Europe Holdings was recently awarded a $40 million multi-year contract for a nationwide transformation project for His Majesty’s Passport Office.

    Equities Trading DOWN

    • Lyra Therapeutics, Inc (NASDAQ:LYRA) shares dropped 90% to $0.4013 after the company announced the ENLIGHTEN 1 trial did not meet its primary endpoint.
    • Shares of GlycoMimetics, Inc (NASDAQ:GLYC) were down 79% to $0.3831 after the company announced topline results from its Phase 3 global pivotal study of uproleselan in relapsed/refractory acute myeloid leukemia (R/R AML).
    • EyePoint Pharmaceuticals, Inc (NASDAQ:EYPT) was down, falling 39% to $11.99 after the company’s Phase 2 PAVIA trial of DURAVYU did not meet its pre-specified primary endpoint.

    Also Check This Out: Top 2 Consumer Stocks That May Plunge This Quarter

    Commodities

    In commodity news, oil traded up 0.7% to $78.63 while gold traded up 0.9% at $2,329.90.

    Silver traded up 2.9% to $27.45 on Monday, while copper rose 1.3% to $4.6165.

    Euro zone

    European shares were higher today. The eurozone's STOXX 600 rose 0.5%, Germany's DAX rose 0.9% and France's CAC 40 gained 0.4%. Spain's IBEX 35 Index rose 0.5%, while London's FTSE 100 rose 0.5%.

    Asia Pacific Markets

    Asian markets closed mixed on Monday, with Japan's Nikkei falling 0.1%, Hong Kong's Hang Seng Index jumping 0.55% and India's S&P BSE Sensex rising 0.02%.

    Economics

    No major economic reports will be released today.

    Get the next $EYPT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EYPT
    $GLYC
    $LYRA
    $SGE

    CompanyDatePrice TargetRatingAnalyst
    Tyson Foods Inc.
    $TSN
    1/8/2026$67.00Market Perform → Outperform
    BMO Capital Markets
    Tyson Foods Inc.
    $TSN
    8/20/2025$60.00Neutral
    Analyst
    Tyson Foods Inc.
    $TSN
    7/23/2025$59.00Outperform → Mkt Perform
    Bernstein
    Tyson Foods Inc.
    $TSN
    6/23/2025$67.00Buy
    Goldman
    EyePoint Inc.
    $EYPT
    6/17/2025$28.00Outperform
    RBC Capital Mkts
    GlycoMimetics Inc.
    $GLYC
    3/21/2025Overweight
    Cantor Fitzgerald
    Tyson Foods Inc.
    $TSN
    2/4/2025$58.00 → $58.00Underweight → Neutral
    Piper Sandler
    Tyson Foods Inc.
    $TSN
    2/3/2025Reduce → Hold
    HSBC Securities
    More analyst ratings

    $EYPT
    $GLYC
    $LYRA
    $SGE
    SEC Filings

    View All

    Tyson Foods Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Other Events, Financial Statements and Exhibits

    8-K - TYSON FOODS, INC. (0000100493) (Filer)

    2/20/26 4:30:47 PM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    SEC Form 424B5 filed by Tyson Foods Inc.

    424B5 - TYSON FOODS, INC. (0000100493) (Filer)

    2/11/26 5:09:42 PM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    Tyson Foods Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits

    8-K - TYSON FOODS, INC. (0000100493) (Filer)

    2/10/26 8:16:20 PM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    $EYPT
    $GLYC
    $LYRA
    $SGE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Everest Group Report Highlights the Growing Role of Intelligent Document Processing in Modernizing Public Sector Service Delivery

    IRVING, Texas, Feb. 18, 2026 (GLOBE NEWSWIRE) -- XBP Global Holdings, Inc. ("XBP Global" or "the Company") (NASDAQ:XBP), a workflow automation leader that leverages decades of industry experience, a global footprint, and agentic AI to rethink business process automation and digital transformation, presents a new report from Everest Group, supported by XBP Global. Public sector organizations worldwide are accelerating the adoption of Intelligent Document Processing ("IDP") to improve service delivery, strengthen compliance, and respond to increasing citizen expectations, according to a new report by Everest Group. The report examines how government agencies are moving away from heavily doc

    2/18/26 8:00:00 AM ET
    $XBP
    EDP Services
    Technology

    EyePoint Appoints Michael Campbell as Chief Commercial Officer

    – Seasoned commercial executive with over 30 years of leadership in retinal disease across biotech and large pharma –– Brings established track record of successful product launches and oversight of prominent ophthalmology franchises, including Lucentis® and Xiidra® – WATERTOWN, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that Michael Campbell has been appointed Chief Commercial Officer. Mr. Campbell, an experienced commercial leader with a proven track record of successful product launches and oversight of

    2/18/26 7:00:00 AM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    WATERTOWN, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company's 2023 Long-Term Incentive Plan in accordance with NASDAQ Listing Rule 5635(c)(4). The Company granted stock options to purchase up to an aggregate of 143,000 shares of EyePoint common stock to six new employees. The stock options were granted on February 13, 2026. The grants were approved by the Compensation Committee and made as an inducement mater

    2/17/26 7:00:00 AM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $EYPT
    $GLYC
    $LYRA
    $SGE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Ribeiro Ramiro sold $36,555 worth of shares (2,437 units at $15.00) and exercised 2,437 shares at a strike of $8.26 (SEC Form 4)

    4 - EyePoint, Inc. (0001314102) (Issuer)

    2/18/26 4:07:08 PM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Chief Legal & Admin Officer Deckinger Adam S. covered exercise/tax liability with 2,715 shares, decreasing direct ownership by 5% to 49,720 units (SEC Form 4)

    4 - TYSON FOODS, INC. (0000100493) (Issuer)

    2/11/26 4:49:11 PM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    Chief People Officer Hanson Jacqueline covered exercise/tax liability with 1,925 shares, decreasing direct ownership by 4% to 43,900 units (SEC Form 4)

    4 - TYSON FOODS, INC. (0000100493) (Issuer)

    2/11/26 4:49:16 PM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    $EYPT
    $GLYC
    $LYRA
    $SGE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Klein Randal T bought $80,325 worth of shares (150,000 units at $0.54) (SEC Form 4)

    4 - XBP Global Holdings, Inc. (0001839530) (Issuer)

    8/19/25 8:23:45 AM ET
    $XBP
    EDP Services
    Technology

    Director Zaderej Karen L. bought $59,000 worth of shares (10,000 units at $5.90), increasing direct ownership by 38% to 36,500 units (SEC Form 4)

    4 - EyePoint Pharmaceuticals, Inc. (0001314102) (Issuer)

    5/19/25 4:06:14 PM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Director Zaderej Karen L. bought $54,450 worth of shares (10,000 units at $5.45), increasing direct ownership by 61% to 26,500 units (SEC Form 4)

    4 - EyePoint Pharmaceuticals, Inc. (0001314102) (Issuer)

    5/15/25 4:06:14 PM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $EYPT
    $GLYC
    $LYRA
    $SGE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tyson Foods upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Tyson Foods from Market Perform to Outperform and set a new price target of $67.00

    1/8/26 8:14:43 AM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    Analyst resumed coverage on Tyson Foods with a new price target

    Analyst resumed coverage of Tyson Foods with a rating of Neutral and set a new price target of $60.00

    8/20/25 9:03:10 AM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    Tyson Foods downgraded by Bernstein with a new price target

    Bernstein downgraded Tyson Foods from Outperform to Mkt Perform and set a new price target of $59.00

    7/23/25 7:47:48 AM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    $EYPT
    $GLYC
    $LYRA
    $SGE
    Leadership Updates

    Live Leadership Updates

    View All

    EyePoint Appoints Michael Campbell as Chief Commercial Officer

    – Seasoned commercial executive with over 30 years of leadership in retinal disease across biotech and large pharma –– Brings established track record of successful product launches and oversight of prominent ophthalmology franchises, including Lucentis® and Xiidra® – WATERTOWN, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that Michael Campbell has been appointed Chief Commercial Officer. Mr. Campbell, an experienced commercial leader with a proven track record of successful product launches and oversight of

    2/18/26 7:00:00 AM ET
    $EYPT
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    XBP Global Appoints Mike Shufeldt as Chief Revenue Officer to Accelerate Growth of XBP Americas

    IRVING, Texas, Jan. 28, 2026 (GLOBE NEWSWIRE) -- XBP Global Holdings, Inc. ("XBP Global" or "the Company") (NASDAQ:XBP), a workflow automation leader that leverages decades of industry experience, a global footprint, and agentic AI to rethink business process automation and digital transformation, announced the appointment of Mike Shufeldt as Chief Revenue Officer (CRO), XBP Americas. In this role, Mr. Shufeldt will lead the revenue strategy and commercial execution, supporting the company's strategic shift toward accelerated, scalable, and client-centric growth in the Americas. The appointment highlights XBP Global's focus on strengthening its go-to-market model, driving solution-led sel

    1/28/26 8:00:00 AM ET
    $XBP
    EDP Services
    Technology

    Tyson Foods to Hold Annual Meeting of Shareholders

    SPRINGDALE, Ark., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE:TSN) will hold its Annual Meeting of Shareholders on Thursday, February 5, 2026 at 11:00 a.m. Eastern time (10 a.m. Central time) at Tyson Foods, 2008 South Thompson Street, Springdale, Arkansas 72764. For shareholders attending in person, an admission ticket is required. Cameras, video and audio recording equipment, as well as large bags are not permitted. Please see our proxy statement, filed on December 17, 2025, for further information. WebcastA link for the webcast of the meeting is available on the Tyson Investor Relations website at https://ir.tyson.com. Audio OnlyParticipants may join the audio-only versi

    1/12/26 4:15:00 PM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    $EYPT
    $GLYC
    $LYRA
    $SGE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lyra Therapeutics Inc.

    SC 13D/A - Lyra Therapeutics, Inc. (0001327273) (Subject)

    12/16/24 9:02:59 PM ET
    $LYRA
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by GlycoMimetics Inc.

    SC 13G - GLYCOMIMETICS INC (0001253689) (Subject)

    11/27/24 2:22:44 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by XBP Europe Holdings Inc.

    SC 13D/A - XBP Europe Holdings, Inc. (0001839530) (Subject)

    11/21/24 8:41:09 PM ET
    $XBP
    EDP Services
    Technology

    $EYPT
    $GLYC
    $LYRA
    $SGE
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $EYPT
    $GLYC
    $LYRA
    $SGE
    Financials

    Live finance-specific insights

    View All

    Tyson Foods Announces Quarterly Dividend

    SPRINGDALE, Ark., Feb. 04, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Tyson Foods (NYSE:TSN), at a meeting on February 4, 2026, declared a quarterly dividend of $0.51 per share on Class A common stock and $0.459 per share on Class B common stock, payable on June 15, 2026, to shareholders of record at the close of business on June 1, 2026. About Tyson Foods, Inc.  Tyson Foods, Inc. (NYSE:TSN) is a world-class food company and recognized leader in protein. Founded in 1935 by John W. Tyson, it has grown under four generations of family leadership. The Company is unified by this purpose: Tyson Foods. We Feed the World Like Family™ and has a broad portfolio of iconic products and brand

    2/4/26 8:05:41 PM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    Tyson Foods Reports First Quarter 2026 Results

    SPRINGDALE, Ark., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE:TSN), one of the world's largest food companies and a recognized leader in protein with leading brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp and State Fair, reported the following results: (in millions, except per share data)First Quarter 2026 2025Sales$14,313  $13,623       Operating Income$302  $580 Adjusted1 Operating Income (non-GAAP)$572  $659       Net Income Per Share Attributable to Tyson$0.24  $1.01 Adjusted1 Net Income Per Share Attributable to Tyson (non-GAAP)$0.97  $1.14  1 The Company reports its financial results in accordance with U.S. generally accepted accou

    2/2/26 7:00:00 AM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples

    Tyson Foods Announces First Quarter Earnings Conference Call and Webcast

    SPRINGDALE, Ark., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Tyson Foods, Inc. (NYSE:TSN) will release first quarter 2026 financial results on Monday, February 2, 2026. Management will host a conference call and webcast beginning at 9:00 a.m. Eastern Time (8:00 a.m. Central Time). A press release and supplemental materials will be issued before the market opens that morning. WebcastA link for the webcast of the conference call will be available on the Tyson Investor Relations website: https://ir.tyson.com. Audio OnlyParticipants may join the audio-only version of the conference call by calling:Dial In (Toll Free): 1-844-890-1795International Dial In: 1-412-717-9589Please note: All dial-in partici

    1/5/26 4:51:59 PM ET
    $TSN
    Meat/Poultry/Fish
    Consumer Staples